EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Endothelial to mesenchymal transition in kidney fibrosis

Marleen E Jacobs, Dorottya K de Vries, Marten A Engelse, Sébastien J Dumas, Ton J Rabelink iD

Nephrology Dialysis Transplantation · 26.04.2024 · 39 (5) · 752-760

DOI: 10.1093/ndt/gfad238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 15.11.2023. Verfasst von Marleen E Jacobs und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (Nephrology) & The Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Lei…. Hauptthemen laut MEDLINE: Fibrosis, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrotic diseases are characterized by the uncontrolled accumulation of extracellular matrix (ECM) components leading to disruption of tissue homeostasis. Myofibroblasts as the main ECM-producing cells can originate from various differentiated cell types after injury. Particularly, the process of endothelial-to-mesenchymal transition (endMT), describing phenotypic shifts of endothelial cells to adopt a fully mesenchymal identity, may contribute to the pool of myofibroblasts in fibrosis, while leading to capillary rarefaction and exacerbation of tissue hypoxia. In renal disease, incomplete recovery from acute kidney injury (AKI) and the ensuing fibrotic reaction stand out as major contributors to chronic kidney disease (CKD) development. While the focus has largely been on impaired tubular epithelial repair as a potential fibrosis-driving mechanism, alterations in the renal microcirculation post-AKI, and in particular endMT as a maladaptive response, could hold equal significance. Dysfunctional interplays among various cell types in the kidney microenvironment can instigate endMT. Transforming growth factor beta (TGF-β) signaling, with its downstream activation of canonical/Smad-mediated and non-canonical pathways, has been identified as primary driver of this process. However, non-TGF-β-mediated pathways involving inflammatory agents and metabolic shifts in intercellular communication within the tissue microenvironment can also trigger endMT. These harmful, maladaptive cell–cell interactions and signaling pathways offer potential targets for therapeutic intervention to impede endMT and decelerate fibrogenesis such as in AKI–CKD progression. Presently, partial reduction of TGF-β signaling using anti-diabetic drugs or statins may hold therapeutic potential in renal context. Nevertheless, further investigation is warranted to validate underlying mechanisms and assess positive effects within a clinical framework.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisEpithelial-Mesenchymal TransitionHumansAnimalsEndothelial CellsKidney Diseases

Stichwörter der Autor:innen

acute kidney injurychronic kidney diseaseendothelial cellsendothelial to mesenchymal transitionfibrogenesis

Autor:innen und Institutionen

  • Department of Internal Medicine (Nephrology) & The Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands.
  • Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Ton J Rabelink

Förderung

  • Novo Nordisk Foundation

Zitieren

APA

Jacobs, M. E., de Vries, D. K., Engelse, M. A., Dumas, S. J., & Rabelink, T. J. (2024). Endothelial to mesenchymal transition in kidney fibrosis. Nephrology Dialysis Transplantation, 39(5), 752-760. https://doi.org/10.1093/ndt/gfad238

Vancouver

Jacobs ME, de Vries DK, Engelse MA, Dumas SJ, Rabelink TJ. Endothelial to mesenchymal transition in kidney fibrosis. Nephrology Dialysis Transplantation. 2024;39(5):752-760. doi:10.1093/ndt/gfad238

BibTeX
@article{Jacobs2024,
  author = {Jacobs, Marleen E and de Vries, Dorottya K and Engelse, Marten A and Dumas, Sébastien J and Rabelink, Ton J},
  title = {Endothelial to mesenchymal transition in kidney fibrosis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {5},
  pages = {752--760},
  doi = {10.1093/ndt/gfad238}
}
Kostenlos starten →